In a strategic move to broaden its oncology portfolio, Merck & Co., Inc. (NYSE: MRK), recognized globally as MSD outside the U.S. and Canada, has announced an exclusive licensing agreement with LaNova Medicines Ltd., a Shanghai-based biotech company. This agreement grants Merck the global rights to develop, manufacture, and commercialize LM-299, an investigational bispecific antibody […]
Shanghai came to a standstill as Typhoon Bebinca, the most powerful storm in 75 years, hit the city on Monday, September 16, 2024, with winds up to 151 km/h. This Category 1 typhoon wreaked havoc, uprooting trees, flooding streets, and disrupting the lives of millions. Bebinca’s impact reminded locals of a storm not seen since […]
In a pivotal agreement poised to bolster the LNG industry, QatarEnergy has inked a partnership accord with China Petrochemical Corporation (Sinopec) for the North Field South (NFS) expansion project. The deal, signed in Shanghai by QatarEnergy’s Minister of State for Energy Affairs, Saad Sherida Al-Kaabi, and Sinopec’s Chairman, Dr. MA Yong-sheng, entails QatarEnergy divesting a […]
In a shocking event that left China’s eastern province of Shandong in devastation, a magnitude 5.5 earthquake struck with fury, injuring 21 unsuspecting residents and reducing 126 structures to rubble, state broadcaster CCTV unveiled. Trains Halted, Buildings Tumble: The Aftermath of the Shandong Tremor The seismic tremor, originating 10 km beneath the Earth’s crust, rumbled […]
Pony.ai, a Chinese autonomous driving company, Toyota Motor (China) Investment Co., Ltd. (TMCI), and GAC Toyota Motor Co., Ltd. (GTMC) held a joint venture signing ceremony today. They announced a partnership aimed at advancing the mass production and large-scale deployment of fully driverless robotaxis, with an estimated investment exceeding RMB 1 billion ($139.2 million). Collaborative […]
Viva Biotech Holdings Group has announced the fundraising of nearly $150 million by transferring about 24% of its equity interest in Viva Shanghai, its chief entity for contract research organization (CRO) business, to Temasek, HighLight Capital (HLC), and True Light. The transaction has additionally resulted in a profit of around $60 million for the publicly […]
Hong Kong-based CLPS Incorporation has announced that its majority-owned subsidiary, JAJI (Shanghai), has initiated the development of a new smart cockpit product aimed at enhancing the safety of intelligent vehicles. The product and its associated solution are expected to be officially launched by the end of 2023. JAJI’s smart cockpit product is tailored to meet […]
Pulse Medical Technology has announced that its fourth-generation μFR system has received breakthrough device designation from the US Food and Drug Administration (FDA) for pan-vascular diagnosis. The Shanghai-based company founded in 2015, is dedicated to developing innovative technology for precise diagnosis and optimal treatment of patients with pan-vascular disease. It is said to have pioneered […]
LaNova Medicines has signed an exclusive license deal worth over $600 million for its pre-clinical stage antibody drug conjugate (ADC) called LM-305 with AstraZeneca. LM-305 is designed to target G protein-coupled receptor, class C, group 5, member D (GPRC5D). The antibody drug conjugate consists of an anti-GPRC5D monoclonal antibody, a cytotoxic payload monomethyl auristatin E […]
G7, a software service provider for the Chinese road freight industry, has raised $200 million in a new funding round led by Shanghai-based private equity firm Trustbridge Partners and CS Capital, a US-based investment company. According to G7, its early investors also took part in the funding round. The Chinese software company caters to freight […]